LMO2 Gene

LIM Domain Only 2: A Key Regulator in Hematopoiesis and Oncogenesis

Gene Information Card

Symbol LMO2
Full Name LIM domain only 2
Gene Type Protein coding
Chromosomal Location 11p13
NCBI Gene ID 4005 ncbi.nlm.nih.gov/gene/4005
Ensembl ID ENSG00000135363
UniProt ID P25791
OMIM ID 180385
HGNC ID 6642
Aliases RBTN2, TTG2, RBTNL1

Description

LMO2 (LIM domain only 2) encodes a cysteine-rich LIM domain protein that functions as a transcriptional regulator. It is essential for hematopoiesis, particularly erythropoiesis and angiogenesis. LMO2 acts as a bridging molecule in transcription factor complexes, often interacting with GATA1, TAL1, and LDB1. Aberrant expression due to chromosomal translocations or retroviral insertions is strongly associated with T-cell acute lymphoblastic leukemia (T-ALL).

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
T-cell acute lymphoblastic leukemia Chromosomal translocations (e.g., t(11;14)(p13;q11)) cause LMO2 overexpression, disrupting T-cell differentiation. ClinVar, OMIM, COSMIC
Angioimmunoblastic T-cell lymphoma LMO2 overexpression via promoter hypomethylation or copy number gains. COSMIC, NCBI
Hemoglobinopathies (indirect) LMO2 is required for erythropoiesis; dysregulation may affect red blood cell development. UniProt, NCBI

Expression Profile

Tissue Expression
Tissue nTPM level
Bone marrow 12.5 Medium
Spleen 8.3 Medium
Thymus 6.7 Low
Lymph node 5.1 Low
Brain 1.2 Not detected
Cell Line Expression
Cell Line nTPM Notes
K562 (erythroleukemia) 45.2 High expression; used as model for erythropoiesis
Jurkat (T-cell leukemia) 32.8 High expression; relevant to T-ALL
HEK293 (embryonic kidney) 2.1 Low endogenous expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
t(11;14)(p13;q11) Translocation Common in T-ALL LMO2 placed under TCR regulatory elements, causing overexpression
c.1A>G (p.Met1?) Missense Rare Potential loss of start codon; effect uncertain
Amplification (11p13) Copy number gain ~5% in T-ALL Increased LMO2 expression
Mutation functional classification

Loss of Function (LOF)

Not commonly reported; LMO2 is essential for normal hematopoiesis, and loss-of-function is likely embryonic lethal.

Gain of Function (GOF)

Overexpression due to translocation or amplification drives T-ALL by blocking T-cell differentiation and promoting proliferation.

Dominant Negative (DN)

Not described for LMO2.

Pathways

Hematopoietic stem cell differentiation (Reactome: R-HSA-9616222)
Transcriptional regulation by LMO2/TAL1 complex (Reactome: R-HSA-9616225)
T-cell receptor signaling in T-ALL (KEGG: hsa05260)

Protein Summary

LMO2 is a 156-amino acid protein containing two LIM zinc-binding domains. It lacks a DNA-binding domain and functions as a scaffold, bridging transcription factors such as GATA1, TAL1, and LDB1. This complex regulates genes critical for erythroid and T-cell development. In cancer, LMO2 overexpression disrupts normal differentiation, contributing to leukemogenesis.

Related Products

Product name Cat.No. Species Gene ID
LMO2 Knockout HEK293 Cell Line EDJ-KQ5130 Human 4005 Details Get a Quote
ELMO2 Knockout HEK293 Cell Line EDJ-KQ13274 Human 63916 Details Get a Quote
LMO2 Knockout HCT 116 Cell Line EDJ-KQ28092 Human 4005 Details Get a Quote
ELMO2 Knockout A-549 Cell Line EDJ-KQ42689 Human 63916 Details Get a Quote
ELMO2 Knockout HCT 116 Cell Line EDJ-KQ42690 Human 63916 Details Get a Quote
ELMO2 Knockout HeLa Cell Line EDJ-KQ42691 Human 63916 Details Get a Quote
LMO2 Knockout HeLa Cell Line EDJ-KQ53797 Human 4005 Details Get a Quote
LMO2 Knockout A-549 Cell Line EDJ-KQ62275 Human 4005 Details Get a Quote
Displaying Records 1 To 8 Of 8 Records
Contact Us
*
*
*
*
How did you hear about us: